In summary, we reported herein the highly correlated expression between the cell surface biomarker CD90 and SHH‐related signalling components Gli1 and Gli3 in liver cancer cells and tissues, as well as the mediating roles of SHH/Gli signalling in the regulation of CD90+ liver cancer stem cell function. The gene discussed is THY1; the disease is liver cancer.